1. Home
  2. YOOV vs TNYA Comparison

YOOV vs TNYA Comparison

Compare YOOV & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concorde International Group Ltd Class A Ordinary Shares

YOOV

Concorde International Group Ltd Class A Ordinary Shares

N/A

Current Price

$0.52

Market Cap

158.7M

ML Signal

N/A

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.84

Market Cap

181.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YOOV
TNYA
Founded
N/A
2016
Country
Singapore
United States
Employees
109
N/A
Industry
Diversified Commercial Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
158.7M
181.5M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
YOOV
TNYA
Price
$0.52
$0.84
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.33
AVG Volume (30 Days)
3.4M
2.7M
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.96
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$0.53
52 Week High
$1.11
$2.35

Technical Indicators

Market Signals
Indicator
YOOV
TNYA
Relative Strength Index (RSI) 51.24 54.78
Support Level $0.36 $0.65
Resistance Level $0.79 $0.94
Average True Range (ATR) 0.15 0.07
MACD -0.01 0.01
Stochastic Oscillator 20.55 54.70

Price Performance

Historical Comparison
YOOV
TNYA

About YOOV Concorde International Group Ltd Class A Ordinary Shares

Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. The Majority revenue is generated from Security Services.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: